Switch to:

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Cole G BradleyCOO2016-12-06Sell5,00035,882$30.61153.050.6535,882 (Direct)
Popovits Kimberly JPresident and CEO
(Click for the stocks that their CEOs have bought)
2016-12-05Sell5,000289,594$30.02150.12.6359,620 (Direct)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
200,851 (Held by the Popovits 2010 Trust)
Leber LauraChief Communication Officer2016-11-21Sell7,06814,331$31.73224.27-2.914,331 (Direct)
Shak StevenChief Scientific Officer2016-11-10Sell5,000327,207$31.71158.55-2.84327,207 (Direct)
Cole G BradleyCOO2016-11-08Sell5,00035,426$29.68148.43.8135,426 (Direct)
Popovits Kimberly JPresident and CEO2016-11-03Sell5,313289,594$28.88153.446.6859,620 (Direct)
200,851 (Held by the Popovits 2010 Trust)
12,298 (Held by UBS for Benefit of Kimberly Popovits)
16,825 (Held in trust for the benefit of Ms. Popovits' son, of which Ms. Popovits is trustee.)
Shak StevenChief Scientific Officer2016-10-11Sell5,000327,207$30.39151.951.38327,207 (Direct)
Cole G BradleyCOO2016-10-10Sell8,29035,426$30.59253.590.7235,426 (Direct)
Vaughn James JChief Commercial Officer2016-10-06Sell3,00026,079$29.6889.043.8126,079 (Direct)
Shak StevenChief Scientific Officer2016-09-13Sell5,000327,207$26.83134.1514.83327,207 (Direct)
Cole G BradleyCOO2016-09-06Sell4,00035,426$27.41109.6412.435,426 (Direct)
Shak StevenChief Scientific Officer2016-08-23Sell5,000327,207$27.24136.213.11327,207 (Direct)
BAKER FELIXDirector, 10% Owner2016-08-15Buy100,00011,841,478$27.02270214.03
318,623 (See footnote(,))
11,348,958 (See footnote(,,))
173,897 (See footnote(F1,))
Cole G BradleyCOO2016-08-11Sell5,00035,426$28.87144.356.7235,426 (Direct)
Vaughn James JChief Commercial Officer2016-08-08Sell3,00029,079$28.7486.227.229,079 (Direct)
Shak StevenChief Scientific Officer2016-07-19Sell5,000327,207$27.42137.112.36327,207 (Direct)
Cole G BradleyCOO2016-07-06Sell5,00035,426$26.64133.215.6535,426 (Direct)
Shak StevenChief Scientific Officer2016-06-21Sell5,000327,207$25.77128.8519.56327,207 (Direct)
Cole G BradleyCOO2016-06-09Sell5,00035,426$26.62133.115.7435,426 (Direct)
Vaughn James JChief Commercial Officer2016-06-06Sell1,99732,079$2855.9210.0432,079 (Direct)
Cole G BradleyCOO2016-05-16Sell5,00034,970$27.613811.6334,970 (Direct)
Febbo Phillip G.Chief Medical Officer2016-05-10Sell6,32415,013$27.2172.0113.2715,013 (Direct)
Vaughn James JChief Commercial Officer2016-05-09Sell2,00031,255$285610.0431,255 (Direct)
Shak StevenChief Scientific Officer2016-05-04Sell10,000326,383$25.43254.321.16326,383 (Direct)
Vaughn James JChief Commercial Officer2016-02-09Sell324,076$280.0810.0424,076 (Direct)
LIVINGSTON RANDALL SDirector2016-01-13Sell1,2506,149$32.1440.18-4.146,149 (Direct)
Cole G BradleyCOO2016-01-12Sell4,00027,428$31.69126.76-2.7827,428 (Direct)
Vaughn James JChief Commercial Officer2016-01-07Sell2,00024,076$33.6367.26-8.3924,076 (Direct)
Cole G BradleyCOO2015-12-08Sell4,00027,428$29.26117.045.327,428 (Direct)
Leber LauraChief Communication Officer2015-12-07Sell4,20012,959$29.33123.195.0512,959 (Direct)
Vaughn James JChief Commercial Officer2015-12-07Sell2,00024,076$29.3358.665.0524,076 (Direct)
Cole G BradleyCOO2015-11-10Sell4,00030,326$26.03104.1218.3630,326 (Direct)
Cole G BradleyCOO2015-09-09Sell9,66430,326$25.35244.9821.5430,326 (Direct)
Cole G BradleyCOO2015-07-07Sell4,00030,326$27.53110.1211.9130,326 (Direct)
Cole G BradleyCOO2015-06-09Sell4,00030,326$26.24104.9617.4230,326 (Direct)
Cole G BradleyCOO2015-05-12Sell4,00029,658$27.54110.1611.8729,658 (Direct)
Popovits Kimberly JPresident and CEO2015-04-13Sell3,000203,001$31.2893.84-1.5Link
Cole G BradleyCOO2015-04-07Sell4,00029,658$30.44121.761.2229,658 (Direct)
Popovits Kimberly JPresident and CEO2015-03-12Sell3,000204,101$31.9195.73-3.45Link
Cole G BradleyCOO2015-03-10Sell4,00029,658$31.84127.36-3.2329,658 (Direct)
Popovits Kimberly JPresident and CEO2015-02-12Sell3,000204,601$29.8689.583.18Link
Cole G BradleyCOO2015-02-10Sell4,00021,645$31.37125.48-1.7921,645 (Direct)
LIVINGSTON RANDALL SDirector2015-02-02Sell1,0006,149$31.9331.93-3.516,149 (Direct)
Popovits Kimberly JPresident and CEO2015-01-12Sell3,000204,601$33.46100.38-7.92Link
Popovits Kimberly JPresident and CEO2014-12-11Sell3,000204,601$32.9998.97-6.61Link
Cole G BradleyCOO2014-12-08Sell4,33621,645$32.52141.01-5.2621,645 (Direct)
Popovits Kimberly JPresident and CEO2014-11-12Sell4,300205,201$34.82149.73-11.52Link
Cole G BradleyCOO2014-11-10Sell4,00022,891$35.35141.4-12.8422,891 (Direct)
LIVINGSTON RANDALL SDirector2014-11-03Sell3,0006,149$36.24108.72-14.986,149 (Direct)
Popovits Kimberly JPresident and CEO2014-10-13Sell3,000205,201$30.7892.340.1Link
Cole G BradleyCOO2014-10-08Sell4,00022,891$28.77115.087.0922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-09-11Sell3,000205,201$29.8289.463.32Link
Cole G BradleyCOO2014-09-08Sell4,70022,891$30.09141.422.3922,891 (Direct)
Shak StevenEVP of R&D2014-08-14Sell13,348312,298$27.36365.212.61312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-08-12Sell3,000205,201$26.0778.2118.18Link
Popovits Kimberly JPresident and CEO2014-07-14Sell3,000205,201$26.5979.7715.87Link
Cole G BradleyCOO2014-07-08Sell2,30022,891$27.0562.2213.922,891 (Direct)
Shak StevenEVP of R&D2014-07-01Sell7,000312,298$2718914.11312,298 (Direct)
Shak StevenEVP of R&D2014-06-12Sell7,000312,298$26.73187.1115.26312,298 (Direct)
Popovits Kimberly JPresident and CEO2014-06-12Sell3,000271,289$26.178.318.05Link
Schorno Dean LCFO2014-06-10Sell4,00030,673$27.62110.4811.5524,524 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2014-06-09Sell2,33722,891$27.2963.7812.922,891 (Direct)
Popovits Kimberly JPresident and CEO2014-05-12Sell3,000270,579$26.5479.6216.09Link
Schorno Dean LCFO2014-05-09Sell4,00029,963$25.09100.3622.823,814 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Shak StevenEVP of R&D2014-04-14Sell7,000311,588$26.25183.7517.37311,588 (Direct)
Cole G BradleyCOO2014-04-08Sell3,00022,226$278114.1122,226 (Direct)
Shak StevenEVP of R&D2014-03-14Sell7,000311,588$28.36198.528.64311,588 (Direct)
Cole G BradleyCOO2014-03-10Sell3,00022,226$27.7683.2810.9922,226 (Direct)
HIBBS KATHY LSVP & General Counsel2014-02-18Sell1,31215,787$27.8836.5810.5115,787 (Direct)
Shak StevenEVP of R&D2014-02-14Sell7,000311,588$27.38191.6612.53311,588 (Direct)
Cole G BradleyCOO2014-02-10Sell3,00024,789$278114.1124,789 (Direct)
Shak StevenEVP of R&D2014-01-15Sell7,000308,283$31.51220.57-2.22308,283 (Direct)
Popovits Kimberly JPresident and CEO2014-01-13Sell2,500261,190$30752.7Link
Cole G BradleyCOO2014-01-08Sell3,00018,369$28.1784.519.3718,369 (Direct)
Shak StevenEVP of R&D & CMO2013-12-17Sell14,000308,283$29.57413.984.19308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-12-12Sell2,5000$30.6876.70.42Link
Schorno Dean LCFO2013-12-09Sell3,00027,706$33.2599.75-7.3421,557 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-12-02Sell1,0006,149$34.9234.92-11.776,149 (Direct)
Popovits Kimberly JPresident and CEO2013-11-13Sell5,0000$34.58172.9-10.9Link
Schorno Dean LCFO2013-11-08Sell3,00027,585$33.36100.08-7.6421,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-11-06Sell2,86818,135$31.3890-1.8218,135 (Direct)
Shak StevenEVP of R&D & CMO2013-10-15Sell5,000308,283$29.67148.353.84308,283 (Direct)
Popovits Kimberly JPresident and CEO2013-10-10Sell2,5000$30752.7Link
Cole G BradleyCOO2013-10-09Sell2,50018,135$29.9574.882.8718,135 (Direct)
Shak StevenEVP of R&D & CMO2013-09-18Sell5,000313,283$33.73168.65-8.66313,283 (Direct)
Popovits Kimberly JPresident and CEO2013-09-12Sell2,5000$34.3185.78-10.2Link
Cole G BradleyCOO2013-09-09Sell2,50018,135$32.5381.33-5.2918,135 (Direct)
Schorno Dean LCFO2013-09-06Sell4,00027,585$32.9131.6-6.3521,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2013-09-03Sell1,0006,149$31.4931.49-2.166,149 (Direct)
Shak StevenEVP of R&D & CMO2013-08-14Sell5,000318,283$32.98164.9-6.58318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-08-12Sell2,5000$33.0382.58-6.72Link
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-7.0621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-08-09Sell4,00027,585$33.15132.6-7.0621,436 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-08-07Sell2,50019,135$33.6684.15-8.4719,135 (Direct)
Shak StevenEVP of R&D & CMO2013-07-23Sell5,000318,283$35.33176.65-12.79318,283 (Direct)
Popovits Kimberly JPresident and CEO2013-07-12Sell5,0000$34.61173.05-10.98Link
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-8.8717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2013-07-09Sell4,00023,985$33.81135.24-8.8717,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-07-08Sell2,50013,135$33.3383.33-7.5613,135 (Direct)
Shak StevenEVP of R&D & CMO2013-06-18Sell5,000323,283$33.52167.6-8.08323,283 (Direct)
Popovits Kimberly JPresident and CEO2013-06-12Sell5,0000$35.68178.4-13.65Link
Schorno Dean LCFO2013-06-10Sell4,00023,985$35.88143.52-14.1317,836 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-06-05Sell2,50013,135$36.4791.18-15.5213,135 (Direct)
BAKER FELIXDirector, 10% Owner2013-06-05Buy381,43213,288,253$36.1613792.58-14.8
1,730,777 (See Footnote)
11,241,654 (See Footnotes(F7,F14,F15))
301,215 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-06-03Buy179,58312,906,821$36.716592.49-16.07
1,690,226 (See Footnote)
10,909,066 (See Footnotes(F7,F14,F15))
292,922 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-06-03Sell1,0006,149$36.436.4-15.366,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-29Buy121,26612,727,238$36.894473.5-16.48
1,671,081 (See Footnote)
10,752,532 (See Footnotes(F7,F14,F15))
289,018 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-05-24Buy79,41714,257,273$36.932932.87-16.57
1,651,301 (See Footnote)
10,646,920 (See Footnotes(F7,F17,F18))
286,384 (See Footnotes(F9,F17,F18))
1,658,061 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-22Sell1,0007,087$37.4837.48-17.87,087 (Direct)
Shak StevenEVP of R&D & CMO2013-05-21Sell5,000327,380$37.19185.95-17.16327,380 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-16Buy71,43912,526,555$36.452603.95-15.47
1,649,473 (See Footnote)
10,577,816 (See Footnotes(F7,F14,F15))
284,659 (See Footnotes(F9,F14,F15))
14,607 (See Footnote(F9,F14,F15))
LIVINGSTON RANDALL SDirector2013-05-15Sell1,3376,149$35.8347.9-14.016,149 (Direct)
BAKER FELIXDirector, 10% Owner2013-05-14Buy240,42614,093,759$34.348256.23-10.28
1,638,643 (See Footnote)
10,515,769 (See Footnotes(F7,F17,F18))
283,112 (See Footnotes(F9,F17,F18))
1,641,628 (See Footnotes(F5,F17,F18))
14,607 (See Footnote(F9,F17,F18))
HIBBS KATHY LSVP & General Counsel2013-05-13Sell1,2507,087$34.4243.03-10.497,087 (Direct)
Popovits Kimberly JPresident and CEO2013-05-13Sell5,0000$34.7173.5-11.21Link
Schorno Dean LCFO2013-05-09Sell4,00023,241$36.02144.08-14.4617,092 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-05-08Sell2,50012,540$35.9989.98-14.3912,540 (Direct)
Popovits Kimberly JPresident and CEO2013-04-23Sell2,5000$30752.7Link
Cole G BradleyCOO2013-04-03Sell2,50012,540$27.7969.4810.8712,540 (Direct)
Cole G BradleyCOO2013-03-06Sell2,50012,540$28.5771.437.8412,540 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-21Buy49,08512,211,834$27.781363.5810.91
1,614,513 (See Footnote)
10,306,239 (See Footnotes(F7,F14,F15))
277,189 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
HIBBS KATHY LSVP & General Counsel2013-02-20Sell2,7167,087$28.1376.49.537,087 (Direct)
MYERS WOODROW A JRDirector2013-02-14Sell41,2502,891$28.41171.58.492,891 (Direct)
BAKER FELIXDirector, 10% Owner2013-02-14Buy52,00012,162,749$28.481480.968.18
1,609,152 (See Footnote)
10,263,580 (See Footnotes(F7,F14,F15))
276,124 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
BAKER FELIXDirector, 10% Owner2013-02-11Buy116,36012,110,749$28.153275.539.45
1,603,265 (See Footnote)
10,218,600 (See Footnotes(F7,F14,F15))
274,991 (See Footnotes(F9,F14,F15))
13,893 (See Footnote(F9,F14,F15))
Cole G BradleyCOO2013-02-06Sell2,50014,085$28.0370.089.9214,085 (Direct)
LIVINGSTON RANDALL SDirector2013-01-28Sell2,0006,149$28.7757.547.096,149 (Direct)
Schorno Dean LCFO2013-01-09Sell2,62523,504$2873.510.0417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2013-01-09Sell2,50014,085$27.8869.710.5114,085 (Direct)
Shak StevenEVP of R&D & CMO2012-12-18Sell5,000333,768$27.74138.711.07333,768 (Direct)
Popovits Kimberly JPresident and CEO2012-12-13Sell5,0000$27.79138.9510.87Link
Schorno Dean LCFO2012-12-11Sell3,00023,504$288410.0417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
LIVINGSTON RANDALL SDirector2012-11-26Sell2,0006,149$27.8455.6810.676,149 (Direct)
BAKER FELIXDirector, 10% Owner2012-11-21Buy229,30012,263,857$26.836152.1214.83288 (Direct)
271,800 (See Footnote)
1,589,551 (See Footnotes(F5,F14,F15))
10,117,174 (See Footnotes(F7,F14,F15))
271,806 (See Footnotes(F9,F14,F15))
13,238 (See Footnote(F9,F14,F15))
Shak StevenEVP of R&D & CMO2012-11-20Sell5,000338,768$26.94134.714.37338,768 (Direct)
COLELLA SAMUEL DDirector2012-11-20Sell30,61636,437$26.89823.2614.5836,437 (Direct)
0 (Versant Venture Capital I, L.P.)
0 (Versant Side Fund I, L.P.)
0 (Versant Affiliates Fund I-A, L.P.)
0 (Versant Affiliates Fund I-B, L.P.)
BAKER FELIXDirector, 10% Owner2012-11-14Buy103,16713,526$27.322818.5212.77288 (Direct)
13,238 (See Footnote)
Popovits Kimberly JPresident and CEO2012-11-14Sell5,0000$27.24136.213.11Link
BAKER FELIXDirector, 10% Owner2012-11-13Buy823,77213,526$27.8122909.110.79288 (Direct)
13,238 (See Footnote)
Schorno Dean LCFO2012-11-12Sell3,00023,504$288410.0417,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-11-08Sell2,50014,085$28.6271.557.6514,085 (Direct)
Popovits Kimberly JPresident and CEO2012-10-16Sell10,0000$33.08330.8-6.86Link
Shak StevenEVP of R&D & CMO2012-10-16Sell5,000343,768$35.25176.25-12.6343,768 (Direct)
Schorno Dean LCFO2012-10-12Sell3,00023,504$33.79101.37-8.8217,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
HIBBS KATHY LSVP & General Counsel2012-10-11Sell1,25011,367$33.7842.23-8.7911,367 (Direct)
Cole G BradleyCOO2012-10-09Sell2,50014,085$34.887-11.4714,085 (Direct)
Shak StevenEVP of R&D & CMO2012-09-18Sell5,000348,768$33.76168.8-8.74348,768 (Direct)
Popovits Kimberly JPresident and CEO2012-09-13Sell5,0000$31.69158.45-2.78Link
Cole G BradleyCOO2012-09-06Sell2,50014,085$35.0187.53-1214,085 (Direct)
MYERS WOODROW A JRDirector2012-08-21Sell16,5002,236$35.2580.8-12.472,236 (Direct)
Shak StevenEVP of R&D & CMO2012-08-20Sell5,000353,768$34.99174.95-11.95353,768 (Direct)
Popovits Kimberly JPresident and CEO2012-08-13Sell10,0000$34.72347.2-11.26Link
Cole G BradleyCOO2012-08-08Sell2,50014,085$30.4976.231.0514,085 (Direct)
LIVINGSTON RANDALL SDirector2012-07-26Sell2,0006,149$35.971.8-14.186,149 (Direct)
Shak StevenChief Medical Officer2012-07-24Sell5,000358,768$34.24171.2-10.02358,768 (Direct)
Popovits Kimberly JPresident and CEO2012-07-13Sell7,1000$34.76246.8-11.36Link
Scott Randal WCEO, InVitae Corporation*2012-07-11Sell30,0000$35.391061.7-12.94Link
Cole G BradleyCOO2012-07-05Sell2,50014,085$35.9589.88-14.314,085 (Direct)
Shak StevenChief Medical Officer2012-06-25Sell5,000363,768$33.25166.25-7.34363,768 (Direct)
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-7.64Link
Popovits Kimberly JPresident and CEO2012-06-13Sell5,0000$33.36166.8-7.64Link
Scott Randal WCEO, InVitae Corporation*2012-06-12Sell30,0000$33.541006.2-8.14Link
Cole G BradleyCOO2012-06-06Sell2,50013,507$33.9784.93-9.313,507 (Direct)
Shak StevenChief Medical Officer2012-05-24Sell5,000367,849$33.8169-8.85367,849 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-22Buy167,4061,488,539$32.265400.52-4.49
1,488,539 (See Footnote)
COLELLA SAMUEL DDirector2012-05-18Sell26,294664,113$33.03868.49-6.7226,891 (Direct)
582,174 (Versant Venture Capital I, L.P.)
11,210 (Versant Side Fund I, L.P.)
13,222 (Colella Family Partners, L.P.)
10,414 (Versant Affiliates Fund I-A, L.P.)
20,202 (Versant Affiliates Fund I-B, L.P.)
BAKER JULIANDirector, 10% Owner2012-05-16Buy376,0591,488,539$33.8812740.88-9.06
1,488,539 (See Footnote)
Popovits Kimberly JPresident and CEO2012-05-16Sell10,0000$34.23342.3-9.99Link
Schorno Dean LCFO2012-05-15Sell1,00023,504$33.6933.69-8.5517,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
BAKER JULIANDirector, 10% Owner2012-05-11Buy114,8881,488,539$29.963442.042.84
1,488,539 (See Footnote)
Scott Randal WCEO, InVitae Corporation*2012-05-11Sell30,0000$30.22906.61.95Link
Cole G BradleyCOO2012-05-09Sell2,50013,507$28.8772.186.7213,507 (Direct)
BAKER JULIANDirector, 10% Owner2012-05-08Buy195,70113,238$28.455567.698.3
13,238 (See Footnote)
LIVINGSTON RANDALL SDirector2012-04-26Sell2,0006,149$28.2156.429.226,149 (Direct)
Shak StevenChief Medical Officer2012-04-24Sell5,000372,849$27.93139.6510.31372,849 (Direct)
Popovits Kimberly JPresident and CEO2012-04-23Sell5,0000$27.79138.9510.87Link
Schorno Dean LCFO2012-04-16Sell1,00024,504$27.9827.9810.1118,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation*2012-04-11Sell20,0000$28.59571.87.76Link
Cole G BradleyCOO2012-04-04Sell2,50013,507$30.2875.71.7513,507 (Direct)
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.42.43377,849 (Direct)
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.352.46Link
Popovits Kimberly JPresident and CEO2012-03-22Sell5,0000$30.07150.352.46Link
Shak StevenChief Medical Officer2012-03-22Sell5,000377,849$30.08150.42.43377,849 (Direct)
Schorno Dean LCFO2012-03-15Sell1,00025,504$31.0831.08-0.8719,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WCEO, InVitae Corporation2012-03-13Sell30,0000$31.05931.5-0.77Link
Cole G BradleyCOO2012-03-08Sell2,50013,507$29.9474.852.9113,507 (Direct)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-08Buy4,5081,484,977$30.11135.742.32
1,484,977 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-08Buy1,099227,840$30.1133.092.32
227,840 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-08Buy41,5848,255,421$30.111252.092.32
8,255,421 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-03-05Buy261,7618,213,837$29.817803.13.35
8,213,837 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-03-05Buy6,923226,741$29.81206.373.35
226,741 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-03-05Buy31,3321,480,469$29.81934.013.35
1,480,469 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-29Buy6,476219,818$29.06188.196.02
219,818 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-29Buy245,0317,952,076$29.067120.66.02
7,952,076 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-29Buy29,7561,449,137$29.06864.716.02
1,449,137 (Through Partnership)
Popovits Kimberly JPresident and CEO2012-02-24Sell10,0000$28.52858.11Link
Shak StevenChief Medical Officer2012-02-23Sell5,000382,849$28.14140.79.49382,849 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-23Buy114,5187,707,045$28.063213.389.8
7,707,045 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-23Buy3,022213,342$28.0684.89.8
213,342 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-23Buy13,3321,419,381$28.06374.19.8
1,419,381 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-16Buy33,1851,406,049$29.34973.655.01
1,406,049 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-16Buy7,213210,320$29.37211.854.9
210,320 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-16Buy272,9097,592,527$29.378015.344.9
7,592,527 (Through Partnership)
Schorno Dean LCFO2012-02-15Sell1,00026,504$28.7628.767.1320,355 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Schorno Dean LCFO2012-02-15Sell75526,749$28.7621.717.1320,600 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.617.69Link
Baker Brothers Life Sciences CDirector, 10% Owner2012-02-10Buy417,9157,319,618$26.3611016.2416.88
7,319,618 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2012-02-10Buy11,043203,107$26.36291.0916.88
203,107 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2012-02-10Buy66,5831,372,864$26.361755.1316.88
1,372,864 (Through Partnership)
Scott Randal WExecutive Chairman2012-02-10Sell20,0000$26.18523.617.69Link
Cole G BradleyCOO2012-02-08Sell2,50014,450$26.4766.1816.414,450 (Direct)
LIVINGSTON RANDALL SDirector2012-01-26Sell2,0006,149$27.5155.02126,149 (Direct)
Popovits Kimberly JPresident and CEO2012-01-25Sell5,0000$26.42132.116.62Link
Popovits Kimberly JPresident and CEO2012-01-24Sell5,0000$26.62133.115.74Link
Shak StevenChief Medical Officer2012-01-24Sell5,000382,778$26.74133.715.22382,778 (Direct)
Schorno Dean LCFO2012-01-17Sell1,00024,049$282810.0417,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Cole G BradleyCOO2012-01-12Sell2,5007,750$27.5468.8511.877,750 (Direct)
Scott Randal WExecutive Chairman2012-01-11Sell20,0000$27.46549.212.2Link
Shak StevenChief Medical Officer2011-12-22Sell5,000387,778$26.03130.1518.36387,778 (Direct)
Scott Randal WExecutive Chairman2011-12-13Sell20,0000$27.29545.812.9Link
Cole G BradleyCOO2011-12-06Sell2,5007,750$28.5971.487.767,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-12-05Buy3,152192,064$28.1288.639.57
192,064 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-12-05Buy45,9771,306,281$27.661271.7211.39
1,306,281 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-12-05Buy117,7516,901,703$28.123311.169.57
6,901,703 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-23Buy5,5311,260,304$25.91143.3118.91
1,260,304 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-23Buy5,750188,912$25.94149.1618.77
188,912 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-23Buy193,7396,783,952$25.915019.7818.91
6,783,952 (Through Partnership)
Shak StevenChief Medical Officer2011-11-22Sell5,000392,778$26.07130.3518.18392,778 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-16Buy64,5976,590,213$27.711789.9811.19
6,590,213 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-16Buy2,550183,162$27.7170.6611.19
183,162 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-16Buy4581,254,773$27.3512.5312.65
1,254,773 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-14Buy10,106180,612$27.23275.1913.15
180,612 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-14Buy249,3756,525,616$27.236790.4813.15
6,525,616 (Through Partnership)
Scott Randal WExecutive Chairman2011-11-11Sell20,0000$27.24544.813.11Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-09Buy5421,254,315$26.7914.5215.01
1,254,315 (Through Partnership)
Cole G BradleyCOO2011-11-08Sell2,5007,750$26.666.515.837,750 (Direct)
Baker Brothers Life Sciences CDirector, 10% Owner2011-11-07Buy209,5126,276,241$25.945434.7418.77
6,276,241 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-11-07Buy8,847170,506$25.94229.4918.77
170,506 (Through Partnership)
Baker Biotech Capital (GP), LLDirector, 10% Owner2011-11-03Buy1201,253,773$24.482.9425.86
1,253,773 (Through Partnership)
LIVINGSTON RANDALL SDirector2011-10-27Sell2,0006,149$22.0844.1639.546,149 (Direct)
Shak StevenChief Medical Officer2011-10-24Sell5,000392,778$21.76108.841.59392,778 (Direct)
Scott Randal WExecutive Chairman2011-10-11Sell20,0000$22.83456.634.95Link
Cole G BradleyCOO2011-10-06Sell5,0007,750$22.31111.5538.17,750 (Direct)
Scott Randal WExecutive Chairman2011-09-13Sell20,0000$20.81416.248.05Link
Cole G BradleyCOO2011-09-06Sell2,5007,750$22.0855.239.547,750 (Direct)
Shak StevenChief Medical Officer2011-08-24Sell5,000392,778$23.02115.133.84392,778 (Direct)
Scott Randal WExecutive Chairman2011-08-11Sell20,0000$24.44488.826.06Link
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1521.977,750 (Direct)
Cole G BradleyCOO2011-08-08Sell2,5007,750$25.2663.1521.977,750 (Direct)
LIVINGSTON RANDALL SDirector2011-07-27Sell2,0006,149$26.4552.916.486,149 (Direct)
Shak StevenChief Medical Officer2011-07-25Sell5,000392,778$27.61138.0511.59392,778 (Direct)
Scott Randal WExecutive Chairman2011-07-12Sell20,0001,503,444$27.36547.212.611,491,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Cole G BradleyCOO2011-07-06Sell5,0007,750$27.74138.711.077,750 (Direct)
Shak StevenChief Medical Officer2011-06-23Sell5,000392,778$27.12135.613.61392,778 (Direct)
Schorno Dean LCFO2011-06-15Sell1,00025,049$25.9125.9118.9118,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-06-13Sell20,0001,523,444$25.69513.819.931,511,146 (Direct)
12,298 (By Morgan Stanley DW Inc. as Custodian for Randal W. Scott, IRA)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-09Buy119194,415$26.193.1217.64
194,415 (Through Partnership)
14159 capital (GP), LLCDirector, 10% Owner2011-06-09Buy4,388161,659$26.19114.9217.64
161,659 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-09Buy203,6526,059,449$26.25335.6817.6
6,059,449 (Through Partnership)
Cole G BradleyCOO2011-06-06Sell2,5007,750$26.1865.4517.697,750 (Direct)
14159 capital (GP), LLCDirector, 10% Owner2011-06-01Buy4,631157,271$27.34126.6112.69
157,271 (Through Partnership)
Baker Bros. Capital (GP), LLCDirector, 10% Owner2011-06-01Buy112194,296$27.353.0612.65
194,296 (Through Partnership)
Baker Brothers Life Sciences CDirector, 10% Owner2011-06-01Buy181,6935,855,797$27.354969.312.65
5,855,797 (Through Partnership)
Shak StevenChief Medical Officer2011-05-25Sell5,000392,778$25.55127.7520.59392,778 (Direct)
Schorno Dean LCFO2011-05-12Sell1,00026,049$26.4826.4816.3519,900 (Direct)
6,149 (By Charles Schwab & Co. as Custodian for Dean L. Schorno, IRA)
Scott Randal WExecutive Chairman2011-05-11Sell20,0000$26.66533.215.57Link
Cole G BradleyCOO2011-05-09Sell2,5007,750$25.9364.8318.827,750 (Direct)
LIVINGSTON RANDALL SDirector2011-04-27Sell2,0000$26.0452.0818.32Link
Shak StevenChief Medical Officer2011-04-25Sell5,0000$25.38126.921.39Link
Popovits Kimberly JPresident and CEO2011-04-15Sell8,0000$25.49203.9220.87Link
Schorno Dean LCFO2011-04-14Sell1,0000$25.3225.3221.68Link
Scott Randal WExecutive Chairman2011-04-12Sell20,0000$25.96519.218.68Link
Cole G BradleyCOO2011-04-06Sell5,0000$26.91134.5514.49Link
Shak StevenChief Medical Officer2011-03-24Sell5,0000$24.45122.2526.01Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3226.84Link
Schorno Dean LCFO2011-03-15Sell1,0000$23.7923.7929.51Link
Popovits Kimberly JPresident and CEO2011-03-15Sell8,0000$24.29194.3226.84Link
Scott Randal WExecutive Chairman2011-03-11Sell20,0000$25.62512.420.26Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-10Buy70,8560$26.031844.3818.36Link
Cole G BradleyCOO2011-03-08Sell2,5000$25.2363.0822.12Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-08Buy9,6480$25.06241.7822.94Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-08Buy349,5660$25.068760.1222.94Link
COLELLA SAMUEL DDirector2011-03-03Sell34,3200$25.45873.4421.06Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-03-02Buy160,3370$25.694119.0619.93Link
14159 capital (GP), LLCDirector, 10% Owner2011-03-02Buy4,4260$25.69113.719.93Link
Baker Brothers Life Sciences CDirector, 10% Owner2011-02-25Buy158,3550$23.393703.9231.72Link
14159 capital (GP), LLCDirector, 10% Owner2011-02-25Buy4,3700$23.39102.2131.72Link
Shak StevenChief Medical Officer2011-02-24Sell5,0000$23.27116.3532.4Link
Schorno Dean LCFO2011-02-15Sell1,0000$22.5122.5136.87Link
Popovits Kimberly JPresident and CEO2011-02-15Sell8,0000$22.51180.0836.87Link
Scott Randal WExecutive Chairman2011-02-11Sell20,0000$22.244438.78Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,0000$21.15169.245.67Link
Popovits Kimberly JPresident and CEO2011-01-18Sell8,000309,424$21.15169.245.67Link
Schorno Dean LCFO2011-01-13Sell1,27626,149$21.0626.8746.3Link
Scott Randal WExecutive Chairman2011-01-11Sell20,0001,642,410$21.73434.641.79Link
Cole G BradleyCOO2011-01-06Sell5,0001,000$22.13110.6539.22Link
Popovits Kimberly JPresident and CEO2010-12-16Sell8,000310,624$22.71181.6835.67Link
Scott Randal WExecutive Chairman2010-12-13Sell20,0001,696,410$22.46449.237.18Link
Cole G BradleyCOO & CFO2010-12-13Sell2,5001,000$22.6456.636.09Link
Popovits Kimberly JPresident and CEO2010-11-16Sell8,000310,624$17.514076.06Link
Cole G BradleyCOO & CFO2010-11-11Sell2,5001,000$18.0445.170.79Link
Scott Randal WExecutive Chairman2010-11-11Sell20,0001,666,410$18.27365.468.64Link
Scott Randal WExecutive Chairman2010-10-12Sell20,0001,686,410$13.95279120.86Link
Popovits Kimberly JPresident and CEO2010-09-15Sell7,734310,624$15.1116.78104.04Link
Scott Randal WExecutive Chairman2010-09-13Sell20,0001,706,410$14.87297.4107.2Link
Cole G BradleyCOO & CFO2010-09-13Sell2,5001,000$15.0137.53105.26Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-09Buy145134,196$14.812.15108.04Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-09Buy5,2614,934,990$14.8177.92108.04Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-09-02Buy65,4664,929,729$14.46946.64113.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-09-02Buy1,807134,051$14.4626.13113.07Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-30Buy3,415132,244$14.3749.07114.41Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-30Buy123,7114,864,263$14.371777.73114.41Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-23Buy150,4694,740,552$14.522184.81112.19Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-23Buy4,153128,829$14.5260.3112.19Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-18Buy530124,676$14.997.94105.54Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-18Buy19,1874,590,083$14.99287.61105.54Link
Popovits Kimberly JPresident and CEO2010-08-17Sell8,000288,116$15.07120.56104.45Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-13Buy2,924124,146$14.8543.42107.47Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-13Buy105,9104,570,896$14.851572.76107.47Link
Cole G BradleyCOO & CFO2010-08-12Sell2,5001,000$1537.5105.4Link
Scott Randal WExecutive Chairman2010-08-11Sell20,0001,726,410$14.71294.2109.45Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-08-10Buy164,2424,464,986$14.612399.58110.88Link
14159 capital (GP), LLCDirector, 10% Owner2010-08-10Buy4,533121,222$14.6166.23110.88Link
Baker JoffreChief Scientific Officer2010-08-09Sell4,629163,088$14.7568.28108.88Link
Scott Randal WExecutive Chairman2010-07-13Sell20,0001,746,410$12.81256.2140.52Link
Baker JoffreChief Scientific Officer2010-07-07Sell4,629167,717$13.0560.41136.09Link
Scott Randal WExecutive Chairman2010-06-11Sell20,0001,766,410$14.15283117.74Link
Baker JoffreChief Scientific Officer2010-06-10Sell4,629172,346$14.0565.04119.29Link
Popovits Kimberly JPresident and CEO2010-05-17Sell8,000310,624$15.78126.2495.25Link
Cole G BradleyCOO & CFO2010-05-12Sell2,5001,000$15.8739.6894.14Link
Scott Randal WExecutive Chairman2010-05-11Sell20,0001,776,410$15.61312.297.37Link
Baker JoffreChief Scientific Officer2010-05-10Sell4,629176,975$15.5171.898.65Link
Scott Randal WExecutive Chairman2010-04-13Sell20,0001,796,410$16.87337.482.63Link
Cole G BradleyCOO & CFO2010-04-12Sell5,0001,000$16.984.582.31Link
Baker JoffreChief Scientific Officer2010-04-12Sell4,629181,604$16.8878.1482.52Link
Popovits Kimberly JPresident and CEO2010-03-16Sell20,000288,116$19.4538958.41Link
Scott Randal WExecutive Chairman2010-03-11Sell20,0001,800,646$19.338659.64Link
Cole G BradleyCOO & CFO2010-03-11Sell2,5001,000$19.3948.4858.9Link
COLELLA SAMUEL DDirector2010-03-10Sell106,70085,050$19.452075.3258.41Link
Baker JoffreChief Scientific Officer2010-03-08Sell4,629150,120$19.8391.7955.37Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-19Buy3,645116,689$17.0562.1580.7Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-19Buy132,0704,300,744$17.052251.7980.7Link
Scott Randal WExecutive Chairman2010-02-11Sell20,0001,830,646$17.23344.678.82Link
Cole G BradleyCOO & CFO2010-02-11Sell2,5001,000$17.5143.7875.96Link
14159 capital (GP), LLCDirector, 10% Owner2010-02-10Buy9,437113,044$17.01160.5281.13Link
Baker Brothers Life Sciences CDirector, 10% Owner2010-02-10Buy341,8544,168,674$17.015814.9481.13Link
Baker JoffreChief Scientific Officer2010-02-09Sell4,629145,491$17.1479.3479.75Link
Cole G BradleyCOO & CFO2010-01-12Sell5,0001,000$17.2586.2578.61Link
Baker JoffreChief Scientific Officer2010-01-11Sell4,629150,120$17.4780.8776.36Link
Shak StevenChief Medical Officer2009-12-21Sell5,000388,278$20.12100.653.13Link
Popovits Kimberly JPresident and CEO2009-12-15Sell5,000313,506$20.39101.9551.1Link
Cole G BradleyCOO & CFO2009-12-14Sell2,0001,000$20.4240.8450.88Link
Scott Randal WExecutive Chairman2009-12-11Sell12,0001,880,646$20.24242.8852.22Link
Baker JoffreChief Scientific Officer2009-12-08Sell4,629154,749$20.2693.7852.07Link
Popovits Kimberly JPresident and CEO2009-11-17Sell20,000318,506$19.21384.260.39Link
Cole G BradleyCOO & CFO2009-11-12Sell6653,000$20.0413.3353.74Link
Scott Randal WExecutive Chairman2009-11-11Sell12,0001,892,646$19.99239.8854.13Link
Baker JoffreChief Scientific Officer2009-11-10Sell4,629159,378$2092.5854.05Link
Shak StevenChief Medical Officer2009-10-20Sell5,000393,278$20.65103.2549.2Link
Popovits Kimberly JPresident and CEO2009-10-15Sell5,000338,506$20.42102.150.88Link
Scott Randal WExecutive Chairman2009-10-13Sell12,0001,904,646$20.66247.9249.13Link
Baker JoffreChief Scientific Officer2009-10-07Sell4,629164,007$21.179845.54Link
Shak StevenChief Medical Officer2009-09-22Sell5,000398,278$21.13105.6545.81Link
Popovits Kimberly JPresident and CEO2009-09-15Sell5,000343,506$20.73103.6548.63Link
Scott Randal WExecutive Chairman2009-09-11Sell12,0001,916,646$20.67248.0449.06Link
Baker JoffreChief Scientific Officer2009-09-04Sell4,629168,636$20.1293.1453.13Link
Shak StevenChief Medical Officer2009-08-25Sell5,000403,278$20.77103.8548.34Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-17Buy1,839103,607$19.9836.7454.2Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-17Buy66,6303,826,820$19.981331.2754.2Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-17Buy34194,184$19.980.6854.2Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-17Buy11,6571,253,653$19.98232.9154.2Link
Popovits Kimberly JPresident and CEO2009-08-17Sell5,000348,506$19.5397.6557.76Link
Cole G BradleyCOO & CFO2009-08-13Sell5,0003,000$2010054.05Link
Baker Biotech Capital (GP), LLDirector, 10% Owner2009-08-12Buy15,8771,241,996$19.49309.4458.08Link
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-08-12Buy45194,150$19.50.8858Link
Baker Brothers Life Sciences CDirector, 10% Owner2009-08-12Buy90,7543,760,190$19.491768.858.08Link
14159 capital (GP), LLCDirector, 10% Owner2009-08-12Buy2,508101,768$19.4948.8858.08Link
Scott Randal WExecutive Chairman2009-08-11Sell12,0001,928,646$19.42233.0458.65Link
Baker JoffreChief Scientific Officer2009-08-10Sell4,629173,265$19.4890.1758.16Link
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1192.44
Baker JoffreChief Scientific Officer2009-07-08Sell4,629177,894$16.0174.1192.44
Scott Randal WExecutive Chairman2009-06-11Sell6,0001,940,646$18.27109.6268.64
Baker JoffreChief Scientific Officer2009-06-08Sell4,629182,523$17.6981.8974.17
Shak StevenChief Medical Officer2009-05-26Sell5,000408,278$199562.16
14159 capital (GP), LLCDirector, 10% Owner2009-05-21Buy1,10899,260$17.9719.9171.45
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-21Buy90194,161$17.971.6271.45
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-21Buy39,7783,669,436$17.97714.8171.45
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-21Buy25194,105$17.970.4571.45
Popovits Kimberly JPresident and CEO2009-05-15Sell5,000353,506$20.12100.653.13
Scott Randal WExecutive Chairman2009-05-12Sell12,0001,946,646$19.46233.5258.32
Baker Bros. Capital (GP), LLCDirector, 10% Owner2009-05-11Buy88194,080$19.551.7257.6
Baker / Tisch Capital (GP), LLDirector, 10% Owner2009-05-11Buy312194,071$19.556.157.6
Baker Brothers Life Sciences CDirector, 10% Owner2009-05-11Buy137,4663,629,658$19.552687.4657.6
14159 capital (GP), LLCDirector, 10% Owner2009-05-11Buy3,82798,152$19.5574.8257.6
Baker JoffreChief Scientific Officer2009-05-08Sell4,629187,152$19.7291.2856.24
Scott Randal WExecutive Chairman2009-04-14Sell12,0001,958,646$25.47305.6420.97
Baker JoffreChief Scientific Officer2009-04-01Sell4,629191,781$25.27116.9721.92
Scott Randal WExecutive Chairman2009-03-11Sell12,0001,970,646$19.4232.858.81
Baker JoffreChief Scientific Officer2009-03-03Sell4,629196,410$19.1388.5561.06
Cole G BradleyCOO & CFO2009-02-17Sell5,0003,000$21.52107.643.17
Baker JoffreChief Scientific Officer2009-02-12Sell4,629201,039$20.695.3649.56
Baker JoffreChief Scientific Officer2009-02-12Sell4,62922,226$20.695.3649.56
Scott Randal WExecutive Chairman, Director2009-02-11Sell12,0001,982,646$20.85250.247.77
Baker JoffreChief Scientific Officer2009-01-12Sell4,62926,855$19.4189.8558.73
Shak StevenChief Medical Officer2008-12-22Sell100413,278$20.172.0252.75
Baker JoffreChief Scientific Officer2008-12-10Sell4,629205,668$19.2589.1160.05
Baker JoffreChief Scientific Officer2008-12-10Sell4,62931,484$19.2589.1160.05
Scott Randal WCEO, Director2008-12-09Sell12,0001,955,298$18.4220.867.45
Baker JoffreChief Scientific Officer2008-11-12Sell4,629210,297$19.8791.9855.06
Baker JoffreChief Scientific Officer2008-11-12Sell4,62936,113$19.8791.9855.06
Scott Randal WCEO, Director2008-11-11Sell12,0001,967,298$20.05240.653.67
Cole G BradleyEVP & CFO2008-11-10Sell10,0004,000$20.17201.752.75
Scott Randal WCEO, Director2008-10-14Sell12,0001,979,298$20.36244.3251.33
Baker JoffreChief Scientific Officer2008-10-01Sell9,25840,742$22.51208.436.87
Shak StevenChief Medical Officer2008-09-24Sell5,000413,378$22.67113.3535.91
Scott Randal WCEO, Director2008-09-16Sell12,0001,991,298$21.79261.4841.4
Shak StevenChief Medical Officer2008-08-26Sell5,000418,378$22.93114.6534.37
Baker JoffreChief Scientific Officer2008-08-26Sell4,629214,926$22.69105.0335.79
Cole G BradleyEVP & CFO2008-08-18Sell9,2984,000$23.67220.0830.16
Popovits Kimberly JPresident and COO2008-08-15Sell25,000358,506$24.2460627.1
Scott Randal WCEO, Director2008-08-12Sell12,0002,003,298$23.76285.1229.67
Scott Randal WCEO, Director2008-07-15Sell12,0002,015,298$2125246.71
Baker JoffreChief Scientific Officer2008-07-01Sell4,629219,555$19.2689.1559.97
Shak StevenChief Medical Officer2008-06-24Sell100423,378$20254.05
Scott Randal WCEO, Director2008-06-10Sell12,0002,027,298$19.92239.0454.67
Baker Brothers Life Sciences CDirector, 10% Owner2008-06-09Buy320,9833,492,192$19.916390.7754.75
Baker Biotech Capital (GP), LLDirector, 10% Owner2008-06-09Buy76,0151,226,119$19.911513.4654.75
14159 capital (GP), LLCDirector, 10% Owner2008-06-09Buy10,29994,325$19.91205.0554.75
Baker JoffreChief Scientific Officer2008-06-02Sell4,629228,813$17.9983.2871.26
Scott Randal WCEO, Director2008-05-13Sell12,0002,039,298$18.7522564.32
Baker JoffreChief Scientific Officer2008-05-08Sell4,629233,442$19.2789.259.89
Scott Randal WCEO, Director2008-04-15Sell12,0002,051,298$17.22206.6478.92
Scott Randal WCEO, Director2008-03-11Sell12,0002,063,298$18.84226.0863.54
Baker JoffreChief Scientific Officer2008-03-05Sell4,629242,700$20.4894.850.44
Shak StevenChief Medical Officer2008-02-26Sell5,000423,478$20.23101.1552.3
Cole G BradleyEVP & CFO2008-02-19Sell9,0008,298$22.58203.2236.45
Scott Randal WCEO, Director2008-02-12Sell12,0002,075,298$23.01276.1233.9
Baker JoffreChief Scientific Officer2008-02-11Sell4,629247,329$22.94106.1934.31
Scott Randal WCEO, Director2008-01-15Sell12,0002,087,298$25.54306.4820.63
Baker JoffreChief Scientific Officer2008-01-02Sell4,629251,958$22.66104.8935.97
Baker JoffreChief Scientific Officer2007-12-03Sell4,6290$23.1106.9333.38
Popovits Kimberly JPresident and COO2007-11-27Sell6,655383,506$22146.4140.05
Scott Randal WCEO, Director2007-11-09Sell12,0002,111,299$23.07276.8433.55
Baker JoffreChief Scientific Officer2007-11-08Sell4,629265,845$23.21107.4432.74
Scott Randal WCEO2007-10-09Sell12,0002,123,299$20.16241.9252.83
Baker JoffreChief Scientific Officer2007-10-01Sell4,629270,474$19.8491.8455.29
Scott Randal WCEO, Director2007-09-11Sell12,0002,135,299$19.7236.456.4
Scott Randal WCEO2007-09-11Sell12,0002,135,299$19.69236.2856.48
Baker JoffreChief Scientific Officer2007-09-10Sell4,629275,103$19.5790.5957.43
Goldberg Michael DDirector2007-08-23Buy5,3505,350$18.76100.3764.23
Scott Randal WCEO2007-08-15Sell12,0002,147,299$19.91238.9254.75
Baker JoffreChief Scientific Officer2007-08-08Sell4,629279,732$19.4489.9958.49
Scott Randal WCEO2007-07-18Sell12,0002,159,299$21.18254.1645.47
Baker JoffreChief Scientific Officer2007-07-02Sell4,629284,361$19.018862.07
Scott Randal WCEO2007-06-19Sell12,0002,171,299$19.16229.9260.8
Baker JoffreChief Scientific Officer2007-06-01Sell4,629288,990$17.5681.2975.46
Baker Bros. Capital (GP), LLCDirector2007-05-30Buy545193,992$16.328.8988.79
Baker Biotech Capital (GP), LLDirector2007-05-30Buy81,1811,150,104$16.321324.8788.79
Baker Brothers Life Sciences CDirector2007-05-30Buy214,0993,171,209$16.323494.188.79
14159 capital (GP), LLCDirector2007-05-30Buy6,80784,026$16.32111.0988.79
14159 capital (GP), LLCDirector2007-05-24Buy16,26177,219$16.59269.7785.71
Baker Brothers Life Sciences CDirector2007-05-24Buy511,5532,957,110$16.598486.6685.71
Baker Biotech Capital (GP), LLDirector2007-05-24Buy193,9661,068,923$16.593217.985.71
Baker Bros. Capital (GP), LLCDirector2007-05-24Buy1,303193,447$16.5921.6285.71
14159 capital (GP), LLCDirector2007-05-21Buy22,49160,958$15.5348.6198.77
14159 capital (GP), LLCDirector2007-05-21Buy160,958$15.50.0298.77
Baker Brothers Life Sciences CDirector2007-05-21Buy707,4582,445,557$15.510965.698.77
Baker Biotech Capital (GP), LLDirector2007-05-21Buy268,248874,957$15.54157.8498.77
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9598.77
Baker Bros. Capital (GP), LLCDirector2007-05-21Buy1,803192,144$15.527.9598.77
Scott Randal WCEO2007-05-08Sell12,0002,183,299$16.62199.4485.38
Baker JoffreChief Scientific Officer2007-05-08Sell4,629293,619$16.3175.588.9
Scott Randal WCEO2007-04-10Sell12,0002,195,299$17.27207.2478.4
Baker JoffreChief Scientific Officer2007-04-02Sell4,629298,248$17.1679.4379.55
Baker / Tisch Capital (GP), LLDirector2007-03-09Buy3,181193,759$18.2858.1568.54
Baker Bros. Capital (GP), LLCDirector2007-03-09Buy376190,341$18.286.8768.54
Baker Biotech Capital (GP), LLDirector2007-03-09Buy62,325606,709$18.281139.368.54
Baker Brothers Life Sciences CDirector2007-03-09Buy168,5601,738,099$18.283081.2868.54
14159 capital (GP), LLCDirector2007-03-09Buy5,37538,467$18.2898.2668.54
Scott Randal WCEO2007-03-06Sell12,0002,207,299$18.35220.267.9
Baker Bros. Capital (GP), LLCDirector2007-03-02Buy119189,965$18.092.1570.32
14159 capital (GP), LLCDirector2007-03-02Buy1,70733,092$18.0930.8870.32
Baker / Tisch Capital (GP), LLDirector2007-03-02Buy1,072190,578$18.119.470.22
Baker Biotech Capital (GP), LLDirector2007-03-02Buy19,795544,384$18.09358.0970.32
Baker Brothers Life Sciences CDirector2007-03-02Buy53,5331,569,539$18.09968.4170.32
Baker JoffreChief Scientific Officer2007-03-01Sell4,629302,877$18.1884.1669.47
MYERS WOODROW A JRDirector2007-02-21Buy2,00012,000$19.6339.2656.95
Baker Brothers Life Sciences CDirector2007-02-16Buy25,4121,516,006$18.54471.1466.18
Baker Biotech Capital (GP), LLDirector2007-02-16Buy9,396524,589$18.54174.266.18
Baker / Tisch Capital (GP), LLDirector2007-02-16Buy525189,506$18.549.7366.18
14159 capital (GP), LLCDirector2007-02-16Buy81131,385$18.5415.0466.18
Baker Bros. Capital (GP), LLCDirector2007-02-16Buy56189,846$18.541.0466.18
Baker Bros. Capital (GP), LLCDirector2007-02-14Buy579189,790$18.2510.5768.82
Baker / Tisch Capital (GP), LLDirector2007-02-14Buy5,346188,981$18.2597.5668.82
Baker Biotech Capital (GP), LLDirector2007-02-14Buy95,783515,193$18.251748.0468.82
14159 capital (GP), LLCDirector2007-02-14Buy8,25630,574$18.25150.6768.82
Baker Brothers Life Sciences CDirector2007-02-14Buy259,0441,490,594$18.254727.5568.82
Scott Randal WCEO2007-02-13Sell12,0002,219,299$18.12217.4470.03
Baker JoffreChief Scientific Officer2007-02-08Sell4,629307,506$18.9787.8162.41
Baker / Tisch Capital (GP), LLDirector2006-12-06Buy642183,635$21.5813.8542.77
Baker Brothers Life Sciences CDirector2006-12-06Buy34,1731,231,550$21.58737.4542.77
14159 capital (GP), LLCDirector2006-12-06Buy1,12022,318$21.5824.1742.77
Baker Biotech Capital (GP), LLDirector2006-12-06Buy12,237419,410$21.58264.0742.77
MYERS WOODROW A JRDirector2006-12-05Buy10,00010,000$21.97219.740.24
Baker / Tisch Capital (GP), LLDirector2006-12-05Buy9,096182,993$20.6187.3849.56
Baker Biotech Capital (GP), LLDirector2006-12-05Buy173,441407,173$20.63572.8849.56
14159 capital (GP), LLCDirector2006-12-05Buy15,88021,198$20.6327.1349.56
Baker Brothers Life Sciences CDirector2006-12-05Buy484,3331,197,377$20.69977.2649.56
14159 capital (GP), LLCDirector2006-09-08Buy5,3185,318$14.0574.72119.29Link
Baker Biotech Capital (GP), LLDirector2006-09-08Buy75,246233,732$14.051057.21119.29Link
Baker Brothers Life Sciences CDirector2006-09-08Buy237,236713,044$14.053333.17119.29Link
Baker Biotech Capital III (GP)10% Owner2005-10-04Buy136,316252,529$121635.79156.75Link
Baker Biotech Capital II (GP),10% Owner2005-10-04Buy38,684181,478$12464.21156.75Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column), "Shares Owned Following This (Direct & Indirect)" transactions (sixth column), and "Trade Price ($)" (seventh column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported (also split adjusted).

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK